NVS will build a $500M biologics-manufacturing site in Singapore: http://www.sec.gov/Archives/edgar/data/1114448/000110465912072435/a12-25682_16k.htm The facility is expected to be fully operational by the end of 2016. NVS claims that biologics now comprise 25% of its drug pipeline.